Antiviral agent 35
Referencia MBS5821229
Marca : MyBiosource
Antiviral agent 35
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5821229Antiviral agent 35 (compound 4d) serves as a potent orally active Inhibitor of the influenza virus, targeting early stages of viral replication. It suppresses influenza-induced ROS accumulation, autophagy, and apoptosis, along with the inflammatory response… More details
Please Inquire
Product Overview
Online Datasheet in PDFProduct Name
Antiviral agent 35, Biochemical
Full Product Name
Antiviral agent 35
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Molecular Weight
418.47
Formula
C23H18N2O4S
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
2760972-52-7
In_vitro
Antiviral agent 35 (compound 4d), administered to mice orally via gavage at dosages of 25, 50, and 100 mg/kg/day on days 2, 4, and 6 post-H1N1 infection, reduced pulmonary inflammation [1].
Other Notes
Small volumes of Antiviral agent 35 biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for Antiviral agent 35 purchase
MBS5821229 is a biochemical targeting Antiviral agent 35.